References
Richardson C, Agrawal R, Lee J, et al. Esophageal dilatation and interstitial lung disease in systemic sclerosis: a cross-sectional study. Semin Arthritis Rheum. 2016;46:109–14.
Takekoshi D, Arami S, Sheppard TJ, et al. Computed tomography of the esophagus in scleroderma and lung disease. Tohoku J Exp Med. 2015;237:345–52.
Marie I, Dominique S, Levesque H, et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum. 2001;45:346–54.
Savarino E, Bazzica M, Zentilin P, et al. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med. 2009;179:408–13.
Gilson M, Zerkak D, Wipff J, et al. Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases. Eur Respir J. 2010;35:112–7.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This reply refers to the comment available at https://doi.org/10.1007/s00535-019-01629-y.
Rights and permissions
About this article
Cite this article
Kuribayashi, S., Motegi, Si., Hara, K. et al. Response to the letter by Dr. Costa-Moreira, Dr. Peixoto, Dr. Ramalho, and Dr. Macedo regarding our manuscript: “Relationship between esophageal motility abnormalities and skin or lung involvements in patients with systemic sclerosis”. J Gastroenterol 55, 246–247 (2020). https://doi.org/10.1007/s00535-019-01630-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-019-01630-5